共 220 条
[1]
Hernlund E(2013)Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) Arch Osteoporos 8 136-2
[2]
Svedbom A(2001)Osteoporosis in postmenopausal women: diagnosis and monitoring Evid Rep Technol Assess 28 1-177
[3]
Ivergård M(2014)Mortality in British hip fracture patients, 2000–2010: a population-based retrospective cohort study Bone 66 171-627
[4]
Compston J(2011)Osteoporosis update J Midwifery Womens Health 56 615-475
[5]
Cooper C(2007)Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 J Bone Miner Res 22 465-637
[6]
Stenmark J(2009)Adverse effects of bisphosphonates: implications for osteoporosis management Mayo Clin Proc 84 632-172
[7]
McCloskey EV(2011)Safety of drugs used in the treatment of osteoporosis Ther Adv Drug Saf 2 159-195
[8]
Jöhnsson B(2015)A traditional Chinese medicine approach in treating depression by promoting liver qi circulation: a Western medicine perspective Chin Med 6 187-143
[9]
Kanis JA(2017)Association of traditional Chinese medicine therapy and the risk of dementia in patients with hypertension: a nationwide population-based cohort study BMC Complement Altern Med 17 178-661
[10]
Nelson HD(2017)Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study BMJ Open 7 138-868